Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark.
The Novo Foundation was not established until 1951, nearly three decades after the Nordisk Insulin Foundation was created, with Thorvald Pedersen as Chair and with both he and Harald Pedersen as life members of the Board.
In 1973, Novo Terapeutisk Laboratorium and Novo Industri merged and became Novo Industri A/S, the internationally known name.
In 1974, Novo Industri A/S was listed on the Copenhagen Stock Exchange, with the Novo Foundation retaining a controlling interest in accordance with the Articles of Association and the owners’ wishes.
When at last they decided to merge in 1989, they created Novo Nordisk.
|Company Name||Founded Date||Revenue||Employee Size||Job Openings|
|Otsuka America Pharmaceutical||1989||$128.1M||350||47|
Zippia gives an in-depth look into the details of Novo Nordisk, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Novo Nordisk. The employee data is based on information from people who have self-reported their past or current employments at Novo Nordisk. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Novo Nordisk. The data presented on this page does not represent the view of Novo Nordisk and its employees or that of Zippia.
Novo Nordisk may also be known as or be related to Novo Nordisk, Novo Nordisk Inc, Novo Nordisk Inc., Novo Nordisk Pharmaceuticals Inc and Novo Nordisk, Inc.